Protein Profiling with Epstein-Barr Nuclear Antigen-1 Reveals an Interaction with the Herpesvirus-associated Ubiquitin-specific Protease HAUSP/USP7
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
The Epstein-Barr nuclear antigen-1 (EBNA1) protein of Epstein-Barr virus is important for the replication, segregation, and transcriptional activation of latent Epstein-Barr virus genomes; has been implicated in host cell immortalization; and avoids proteasomal processing and cell-surface presentation. To gain insight into how EBNA1 fulfills these functions, we have profiled cellular protein interactions with EBNA1 using EBNA1 affinity chromatography and tandem affinity purification (TAP) of EBNA1 complexes from human cells (TAP-tagging). We discovered several new specific cellular protein interactions with EBNA1, including interactions with HAUSP/USP7, NAP1, template-activating factor-I beta/SET, CK2, and PRMT5, all of which play important cell regulatory roles. The ubiquitin-specific protease USP7 is a known target of herpes simplex virus, and the USP7-binding region of EBNA1 was mapped to amino acids 395-450. A mutation in EBNA1 that selectively disrupted binding to USP7 was found to cause a 4-fold increase in EBNA1 replication activity but had no effect on EBNA1 turnover and cell-surface presentation. The results suggest that USP7 can regulate the replication function of EBNA1 and that EBNA1 may influence cellular events by sequestering key regulatory proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“upon transfection of human epithelial cells (HeLa) with the TAP-tagged viral protein EBNA1 from the herpesvirus Epstein–Barr virus (EBV), Holowaty et al. identified a stable interaction with the cellular deubiquitinating protease USP7/HAUSP [71].”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [71]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“which additionally demonstrated that the EBNA1-USP7 interaction does not require other human proteins.”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [71]
In the citing paper
“The discovered EBNA1-USP7 interaction was confirmed by co-immunoprecipitation in insect cells”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [71]
In the citing paper
“Subsequent functional assays further suggested that the virus may sequester USP7 indirectly to inhibit host-induced apoptosis and promote cell cycle growth.”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A generic protein purification method for protein complex characterization and proteome exploration
Rigaut, G., Shevchenko, A., Rutz, B., Wilm, M., Mann, M., & Séraphin, B. (1999) · Nature Biotechnology · doi:10.1038/13732 · Cited by 2,707
RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO
Hoege, C., Pfander, B., Moldovan, G.-L., Pyrowolakis, G., & Jentsch, S. (2002) · Nature · doi:10.1038/nature00991 · Cited by 2,198
Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells
Yates, J. L., Warren, N., & Sugden, B. (1985) · Nature · doi:10.1038/313812a0 · Cited by 1,292
Protein kinase CK2: structure, regulation and role in cellular decisions of life and death
LITCHFIELD, D. W. (2003) · Biochemical Journal · doi:10.1042/bj20021469 · Cited by 1,233
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., & Gu, W. (2002) · Nature · doi:10.1038/nature737 · Cited by 1,031
Use of mass spectrometric molecular weight information to identify proteins in sequence databases
Mann, M., Højrup, P., & Roepstorff, P. (1993) · Biological Mass Spectrometry · doi:10.1002/bms.1200220605 · Cited by 931
Transport into and out of the Nucleus
Macara, I. G. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.4.570-594.2001 · Cited by 905
Levitskaya, J., Coram, M., Levitsky, V., Imreh, S., Steigerwald-Mullen, P. M., Klein, G., Kurilla, M. G., & Masucci, M. G. (1995) · Nature · doi:10.1038/375685a0 · Cited by 823
Levitskaya, J., Sharipo, A., Leonchiks, A., Ciechanover, A., & Masucci, M. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12616 · Cited by 562
Everett, R. D. (1997) · The EMBO Journal · doi:10.1093/emboj/16.7.1519 · Cited by 492
Research works printed but not linked: 4
- 1. Kieff, E. ∙ Rickinson, A.B. Knipe, D.M. ∙ Howley, P.M. (Editors) Fields Virology Lippincott-Williams & Wilkins, Philadelphia, 2001; 2511-2573 Google Scholar
- 4. Reisman, D. ∙ Yates, J. ∙ Sugden, B. Mol. Cell. Biol. 1985; 5:1822-1832 Crossref Scopus (354) PubMed Google Scholar
- 6. Reisman, D. ∙ Sugden, B. Mol. Cell. Biol. 1986; 6:3838-3846 Crossref Scopus (297) PubMed Google Scholar
- Xiao, 1994, Mol. Cell. Biol., 14, 7507
Cited by
Items 101–200 of 237
USP7/HAUSP Promotes the Sequence-Specific DNA Binding Activity of p53
Sarkari, F., Sheng, Y., & Frappier, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013040 · Cited by 39
“Primary antibodies used were R2B2 for USP7 [29], DO-1 for p53 (Santa Cruz), Ab-1 for Actin (Calbiochem), antibody 187 for p21 (Santa Cruz, sc-817) and antibody A-14 for c-myc (Santa Cruz, sc-789).”
BackgroundMethodInfluentialSelf-citationUSP49 potently stabilizes APOBEC3G protein by removing ubiquitin and inhibits HIV-1 replication
Pan, T. S., Song, Z., Wu, L., Liu, G., Ma, X., Peng, Z., Zhou, M., Liang, L., Liu, B., Liu, J., et al. (2019) · eLife · doi:10.7554/elife.48318 · Cited by 34
“For example, USP7 interacts with the Epstein–Barr nuclear antigen-1 (EBNA1) of Epstein-Barr virus and the ubiquitin E3 ligase ICP0 of the herpes simplex virus type-1 (HSV-1) to affect viral replication (Berardi et al., 2004; Holowaty et al., 2003).”
BackgroundXiang, Q., Ju, H., Li, Q., Mei, S.-C., Chen, D., Choi, Y. B., & Nicholas, J. (2018) · Journal of Virology · doi:10.1128/jvi.02003-17 · Cited by 32
“To determine the released, encapsidated viral genome copy number, LANA ORF-directed quantitative PCR (qPCR) using primer sequences 5=-TACGGTTGGCGAAGTC ACATC-3= (forward) and 5=-CCTCGCAGCAGACTACACCTCCAC-3= (reverse) was applied to DNA extracted from medium samples (300 l) pretreated with DNase I (6 U/ml; 37°C; overnigh…”
BackgroundInfluentialUbiquitination at the interface of tumor viruses and DNA damage responses
Dybas, J. M., Herrmann, C., & Weitzman, M. D. (2018) · Current Opinion in Virology · doi:10.1016/j.coviro.2018.08.017 · Cited by 31
“Saridakis V, Sheng Y, Sarkari F, Holowaty MN, Shire K, Nguyen T, Zhang RG, Liao J, Lee W, Edwards AM, et al.: Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization.”
BackgroundInfluentialForsman, A., Rüetschi, U., Ekholm, J., & Rymo, L. (2008) · Journal of Proteome Research · doi:10.1021/pr700769e · Cited by 38
Gredmark‐Russ, S., Isaacson, M. K., Kattenhorn, L. M., Cheung, E. J., Watson, N., & Ploegh, H. L. (2009) · Journal of Virology · doi:10.1128/jvi.01017-09 · Cited by 31
“The EBV EBNA1 protein interacts with hostderived USP7 (also called “HAUSP”) (17) and is believed to interfere with normal regulation of the mdm2-p53 pathway (reviewed in reference 16).”
BackgroundViral-Targeted Strategies Against EBV-Associated Lymphoproliferative Diseases
Hui, K. F., Yiu, S. P. T., Tam, K. P., & Chiang, A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00081 · Cited by 31
“Inhibition of Apoptosis EBNA-1 can interact with the herpesvirus associated ubiquitinspecific protease to destabilize and degrade p53 to inhibit apoptosis (46).”
BackgroundWyżewski, Z., Mielcarska, M. B., Gregorczyk-Zboroch, K. P., & Myszka, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137265 · Cited by 31
“Research has shown [168] that EBNA-1 is able to interact with herpesvirusassociated ubiquitin-specific protease (HAUSP)/USP7, an enzyme that deubiquitinates and stabilizes p53, promoting p53-mediated apoptotic events.”
BackgroundThe Role of Deubiquitinases in Virus Replication and Host Innate Immune Response
Zhang, Q., Jia, Q., Gao, W., & Zhang, W. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.839624 · Cited by 34
Malik-Soni, N., & Frappier, L. (2013) · Journal of Virology · doi:10.1128/jvi.02521-13 · Cited by 29
“This is similar to EBNA1 interactions with the NAP1 and TAF-1 histone chaperones, which also involve the Gly-Arg-rich EBNA1 regions (11, 12).”
BackgroundMethodSelf-citationRegulation of the Ebola Virus VP24 Protein by SUMO
Vidal, S., Motiam, A. E., Seoane, R., Preitakaitė, V., Bouzaher, Y. H., Gómez-Medina, S., Martín, C. S., Rodríguez, D., Rejas, M. T., Baz-Martínez, M., et al. (2019) · Journal of Virology · doi:10.1128/jvi.01687-19 · Cited by 28
Srivastava, M., Mittal, L., Kumari, A., Agrahari, A. K., Singh, M., Mathur, R., & Asthana, S. (2022) · Protein Science · doi:10.1002/pro.4398 · Cited by 30
FoxO6 inhibits cell proliferation in lung carcinoma through up-regulation of USP7
HU, H.-J., Zhang, L., Wang, Z., & GUO, X.-X. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3362 · Cited by 28
“USP7 is a member of the ubiquitin‑specific protease family, and was initially considered a binding partner of the herpes simplex virus protein Vmw110/ICP0 (20).”
Czech‐Sioli, M., Siebels, S., Radau, S., Zahedi, R. P., Schmidt, C., Dobner, T., Grundhoff, A. T., & Fischer, N. (2019) · Journal of Virology · doi:10.1128/jvi.01638-19 · Cited by 27
“Considering the latter, Usp7 binding is indeed a common feature among viral proteins expressed by large DNA viruses (e.g., herpes simplex virus [HSV; ICP0] [44, 45], Epstein-Barr virus [EBV; EBNA1] [46, 47], Kaposi’s sarcoma herpesvirus [KSHV; LANA, vIRF1, vIRF3, and vIRF4] [48–51], cytomegalovirus [CMV; UL35 and UL35…”
Kanda, T., Horikoshi, N., Murata, T., Kawashima, D., Sugimoto, A., Narita, Y., Kurumizaka, H., & Tsurumi, T. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.491167 · Cited by 26
“For examples, cellular proteins, such as mitochondrial protein p32/TAP (16, 17), a histone chaperone NAP1 (18), and EBP2 (13, 19), have been shown to bind to the regions.”
BackgroundSTUB1 is targeted by the SUMO-interacting motif of EBNA1 to maintain Epstein-Barr Virus latency
Wang, Y., Du, S., Zhu, C., Wang, C., Yu, N., Lin, Z., Gan, J., Guo, Y., Huang, X., He, Y., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008447 · Cited by 29
“Unexpectedly, although USP7 was previously identified as a specifically interacting protein of EBNA1 was previously identified [25], and the assembly of EBNA1 on OriP elements is decreased by USP7 silencing [63], the affinity of UPS7 to EBNA1 does is not significantly different once the EBNA1 motif is deleted.”
BackgroundZhou, L., Ouyang, T., Li, M., Hong, T., Alriashy, M. H. S., Meng, W., & Zhang, N. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.784672 · Cited by 28
“UL35 (29) EBNA1 (30) Foxp3 Tumor evasion (31)”
Electrophilic Sulfonium-Promoted Peptide and Protein Amidation in Aqueous Media
Wan, C., Feng, Y. P., Hou, Z., Lian, C., Zhang, L. N., An, Y., Sun, J., Yang, D., Jiang, C., Yin, F., et al. (2021) · Organic Letters · doi:10.1021/acs.orglett.1c04017 · Cited by 24
Aviles, F., Zhang, M. M., Chan, J., Delamare‐Deboutteville, J., Green, T. J., Dang, C., & Barnes, A. C. (2012) · Veterinary Microbiology · doi:10.1016/j.vetmic.2012.08.018 · Cited by 24
“In contrast the EBNA positive control is strongly basic (pI = 11) (Holowaty et al., 2003) resulting in retardation of the control EBNA/duplex complex in the gel.”
BackgroundUSP7 substrates identified by proteomics analysis reveal the specificity of USP7
Nie, L., Wang, C., Liu, X., Teng, H., Li, S., Huang, M., Feng, X., Pei, G., Hang, Q., Zhao, Z., et al. (2022) · Genes & Development · doi:10.1101/gad.349848.122 · Cited by 33
“USP7 was originally identified as an interaction protein of herpes simplex virus type 1 (HSV1) ICP0, and later as an interaction protein of other viral proteins such as Epstein– Barr virus (EBV) EBNA1 (Everett et al. 1997; Holowaty et al. 2003b; Daubeuf et al. 2009).”
BackgroundMBD4 Interacts With and Recruits USP7 to Heterochromatic Foci
Meng, H., Harrison, D. J., & Meehan, R. R. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25001 · Cited by 23
“Despite different cellular systems and conditions used, previous studies have reported a diffused distribution of USP7 within cell nuclei as well as some cytoplasmic staining [Holowaty et al., 2003; van der Horst et al., 2006].”
MethodResultMacPherson, J. I., Sidders, B. S., Wieland, S. F., Zhong, J., Targett‐Adams, P., Lohmann, V., Backes, P., Delpuech-Adams, O. E., Chisari, F. V., Lewis, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025584 · Cited by 24
“viral replication [34,35].”
Cochrane, A., Murley, L. L., Gao, M., Wong, R., Clayton, K., Brufatto, N., Canadien, V., Mamelak, D., Chen, T., Richards, D. P., et al. (2009) · Virology · doi:10.1016/j.virol.2009.03.005 · Cited by 22
Self-citationHistone modifications in herpesvirus infections
Opdenbosch, N. V., Favoreel, H. W., & de Walle, G. R. V. (2011) · Biology of the Cell · doi:10.1111/boc.201100067 · Cited by 25
“Not only HSV ICP0 but also the EBNA1 protein of EBV was found to interact with this enzyme (Holowaty et al., 2003).”
BackgroundHost–virus interactions: from the perspectives of epigenetics
Li, S., Kong, L., Yu, X., & Zheng, Y. (2014) · Reviews in Medical Virology · doi:10.1002/rmv.1783 · Cited by 22
“EBV has been shown to reduce global H2B ubiquitination [61,62].”
BackgroundIdentification of Protein Interacting Partners Using Tandem Affinity Purification
Bailey, D., Ureña, L., Thorne, L., & Goodfellow, I. (2012) · Journal of Visualized Experiments · doi:10.3791/3643-v · Cited by 21
de Marco, A., Dans, P. D., Knezevich, A., Maiuri, P., Pantano, S., & Marcello, A. (2009) · Amino Acids · doi:10.1007/s00726-009-0378-9 · Cited by 21
“Structural modeling of the complex between hNAP-1 and HIV-1 Tat suggests that Tat binds within the same binding site used by histone tails.”
InfluentialChanging the ubiquitin landscape during viral manipulation of the DNA damage response
Weitzman, M. D., Lilley, C. E., & Chaurushiya, M. S. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.049 · Cited by 21
“The Epstein Barr Virus (EBV) protein EBNA1 also interacts with USP7 [109], suggesting that this isopeptidase may be commonly usurped by viruses.”
BackgroundInfluentialContribution of the Epstein-Barr Virus to the Pathogenesis of Hodgkin Lymphoma
Murray, P. G., & Bell, A. I. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-22822-8_12 · Cited by 20
“In the context of another B-cell tumour, Burkitt lymphoma, EBNA1 has also been shown to contribute anti-apoptotic functions through destabilisation of p53 and induction of the anti-apoptotic gene, survivin (Holowaty et al. 2003; Lu et al. 2011).”
BackgroundImportance of Deubiquitination in Macrophage-Mediated Viral Response and Inflammation
Rasaei, R., Sarodaya, N., Kim, K.-S., Ramakrishna, S., & Hong, S.-H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218090 · Cited by 20
“USP7 interacts with proteins that are important for viral growth and replication like ICP0 (Vmw 110), a herpes simplex virus immediate-early gene [75,76], and Epstein-Barr nuclear antigen-1 (EBNA1), another herpes virus protein [77,78].”
BackgroundObtaining Protein Association Energy Landscape for Integral Membrane Proteins
Rajagopal, N., & Nangia, S. (2019) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.9b00626 · Cited by 21
Mei, Y., Messick, T. E., Dheekollu, J., Kim, H. J., Molugu, S. K., Castro-Muñoz, L. J., Moiskeenkova-Bell, V., Murakami, K., & Lieberman, P. M. (2022) · Journal of Virology · doi:10.1128/jvi.00949-22 · Cited by 19
The Interactome of Protein Kinase CK2
Montenarh, M., & Götz, C. (2013) · Wiley eBooks · doi:10.1002/9781118482490.ch2 · Cited by 19
Therapeutic Strategies against Epstein-Barr Virus-Associated Cancers Using Proteasome Inhibitors
Hui, K. F., Tam, K. P., & Chiang, A. (2017) · Viruses · doi:10.3390/v9110352 · Cited by 18
“Thus, the deubiquitination of p53 by USP7 is blocked, leading to its degradation [33].”
BackgroundXiang, Q., Ju, H., & Nicholas, J. (2019) · Journal of Virology · doi:10.1128/jvi.01553-19 · Cited by 19
“equivalent EBNA1 latency protein of Epstein-Barr virus (36).”
BackgroundSivachandran, N., Thawe, N., & Frappier, L. (2011) · Journal of Virology · doi:10.1128/jvi.05293-11 · Cited by 18
Self-citationEl-Hamaky, A. A., El‐Hamamsy, M. H., El-Moselhy, T. F., Sharafeldin, N., & Tawfik, H. O. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117872 · Cited by 18
Gammaherpesvirus maintenance and replication during latency
Lieberman, P. M., Hu, J., & Renne, R. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545313.025 · Cited by 17
Epstein Barr virus: A cellular hijacker in cancer
Alsaadawe, M., Radman, B. A., Long, J., Alsaadawi, M. A., Fang, W., & Lyu, X. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189218 · Cited by 19
Shire, K., Marcon, E., Greenblatt, J. F., & Frappier, L. (2021) · Virology · doi:10.1016/j.virol.2021.07.009 · Cited by 16
Self-citationAlzhanova, D., Meyo, J. O., Juarez, A., & Dittmer, D. P. (2021) · Journal of Virology · doi:10.1128/jvi.01459-21 · Cited by 20
“One of these motifs, “EGPS” at amino acid position 223 to 226, was also observed in the KSHV vIRF-1 and vIRF-3 proteins, as well as the in the Epstein-Barr Virus nuclear antigen 1 (EBNA1) protein (20, 21, 33).”
BackgroundAntrobus, R., & Boutell, C. (2008) · Virus Research · doi:10.1016/j.virusres.2008.05.017 · Cited by 16
Xin, S., Du, S., Liu, L.-Z., Xie, Y., Zuo, L., Yang, J., Hu, J., Yue, W., Zhang, J., Cao, P., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02879 · Cited by 16
Pavlović, M. D., Jandrlić, D. R., & Mitić, N. S. (2014) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.03.027 · Cited by 15
The Central Role of the Ubiquitin–Proteasome System in EBV-Mediated Oncogenesis
Pei, Y., & Robertson, E. S. (2022) · Cancers · doi:10.3390/cancers14030611 · Cited by 16
“Using affinity chromatography in vitro and tandem affinity purification (TAP)-tagging in vivo approaches, the EBV nuclear antigen 1 (EBNA1) was identified to be associated with several cellular proteins, such as USP7/HAUSP, CK2, PRMT5 [10].”
MethodHigh Avidity Binding to DNA Protects Ubiquitylated Substrates from Proteasomal Degradation
Coppotelli, G., Mughal, N., Marescotti, D., & Masucci, M. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.224782 · Cited by 15
Große, M., Setz, C., Rauch, P., Auth, J., Morokutti-Kurz, M., Temchura, V., & Schubert, U. (2022) · Viruses · doi:10.3390/v14071404 · Cited by 15
G 1 /S Cell Cycle Induction by Epstein-Barr Virus BORF2 Is Mediated by P53 and APOBEC3B
Yockteng-Melgar, J., Shire, K., Cheng, A. Z., Malik-Soni, N., Harris, R. S., & Frappier, L. (2022) · Journal of Virology · doi:10.1128/jvi.00660-22 · Cited by 14
“Construction of pMZS3F-BORF2 and pMZS3F-LacZ used for AP-MS experiments have been previously described (16, 55).”
MethodSelf-citationUbiquitin Ligases in Malignant Lymphoma
Lim, M. S., & Elenitoba‐Johnson, K. S. J. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190410001663635 · Cited by 14
USP7 Inhibitors Destabilize EBNA1 and Suppress Epstein‐Barr Virus Tumorigenesis
Chen, C., Addepalli, K., Soldan, S. S., Castro-Muñoz, L. J., Preston‐Alp, S., Patel, R. J., Albitz, C. J., Tang, H., Tempera, I., & Lieberman, P. M. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70168 · Cited by 13
“The physical interaction of USP7 with EBNA1 has been characterized extensively [22 – 25].”
FR-like EBNA1 binding repeats in the human genome
d’Hérouël, A. F., Birgersdotter, A., & Werner, M. (2010) · Virology · doi:10.1016/j.virol.2010.06.040 · Cited by 13
“EBNA1 also affects cell proliferation in Burkitt's lymphoma (BL) cell lines, which is partly explained by its interaction with HAUSP/USP7, a deubiqitination enzyme that prevents p53 degradation (Kennedy et al., 2003; Sengupta et al., 2006; Holowaty et al., 2003).”
BackgroundTellam, J., Rist, M., Connolly, G., Webb, N., Fazou, C., Wang, F., & Khanna, R. (2007) · European Journal of Immunology · doi:10.1002/eji.200636153 · Cited by 13
Self-citationMansouri, S., Wang, S., & Frappier, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063802 · Cited by 15
“Although EBNA1 can directly interact with TAF-Ib [20,22], the effect of EBNA1 on the TAF-I-BZLF1 promoter”
BackgroundSelf-citationProtein Kinase CK2 and Epstein–Barr Virus
Montenarh, M., Grässer, F. A., & Götz, C. (2023) · Biomedicines · doi:10.3390/biomedicines11020358 · Cited by 14
“Through affinity chromatography and tandem affinity purification (TAP), each CK2 subunit was found to associate with EBNA-1 [91].”
BackgroundKaposi’s sarcoma-associated herpesvirus-encoded LANA positively affects on ubiquitylation of p53
Suzuki, T., Isobe, T., Kitagawa, M., & Ueda, K. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.11.004 · Cited by 12
The roles of ribosomal proteins in nasopharyngeal cancer: culprits, sentinels or both
Sim, E. U., Lee, C. W., & Narayanan, K. (2021) · Biomarker Research · doi:10.1186/s40364-021-00311-x · Cited by 12
The ubiquitin specific protease 7 stabilizes HPV16E7 to promote HPV-mediated carcinogenesis
Xia, C., Xiao, C.-Y., Luk, H. Y., Chan, P. K. S., & Boon, S. S. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04941-2 · Cited by 12
Freire, E., Oddo, C. G., Frappier, L., & Gay, G. D. P. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21580 · Cited by 11
Self-citationBridgewater, H. E., Date, K. L., O’Neil, J. D., Hu, C., Arrand, J. R., Dawson, W. O., & Young, L. S. (2020) · Pathogens · doi:10.3390/pathogens9070594 · Cited by 11
Boddin, J., Ip, W.-H., Wilkens, B., von Stromberg, K., Ching, W., Koyuncu, E., Bertzbach, L. D., & Dobner, T. (2022) · mBio · doi:10.1128/mbio.00144-22 · Cited by 10
Current Trends and Alternative Scenarios in EBV Research
Minárovits, J., & Niller, H. H. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6655-4_1 · Cited by 9
Tsimbouri, P. M., Al‐Sheikh, Y. A., Drotar, M. E., Cushley, W., & Wilson, J. B. (2008) · Journal of General Virology · doi:10.1099/vir.0.83296-0 · Cited by 9
Proteomics methods for discovering viral–host interactions
Georges, A. A., & Frappier, L. (2015) · Methods · doi:10.1016/j.ymeth.2015.05.001 · Cited by 10
Self-citationThe V-val subtype Epstein-Barr virus nuclear antigen 1 promotes cell survival after serum withdrawal
Chao, M., WANG, H.-N., Lü, Y., Chang, Y., & Yu, J. (2014) · Oncology Reports · doi:10.3892/or.2014.3625 · Cited by 9
Genetic evidence identifies a causal relationship between EBV infection and multiple myeloma risk
Li, J., Tan, R., Yang, B. Y., Du, C., Tian, J., Yang, Z., & Tang, D. (2025) · Scientific Reports · doi:10.1038/s41598-025-90479-1 · Cited by 9
“It has been found that EBNA-1 interacts with USP7, leading to ubiquitination and proteasomal degradation, which in turn destabilises p53, thereby promoting cell cycle progression and inhibiting apoptosis 44 .”
3 Diverse roles of protein arginine methyltransferases
McBride, A. E. (2006) · The Enzymes · doi:10.1016/s1874-6047(06)80005-3 · Cited by 9
Vafapour, Z., Hosseini, F., Hosseini, S. Y., Haghighat, S., Hashemi, S. M. A., Moattari, A., & Sarvari, J. (2023) · Archives of Virology · doi:10.1007/s00705-023-05933-0 · Cited by 7
“EBNA1 can also interact with USP7 and destabilize p53, which causes a reduction in its concentration and restricts cell apoptosis and death [13].”
Proteomics Applied to Avian Herpesviruses
Kunec, D. (2013) · Avian Diseases · doi:10.1637/10483-010413-reg.1 · Cited by 8
Detection of Protein–Protein Interactions Using Tandem Affinity Purification
Goodfellow, I., & Bailey, D. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1034-2_10 · Cited by 7
Imai, S., 黒田正幸, 山下, 竜., & 石浦嘉人 (2005) · Uirusu · doi:10.2222/jsv.55.239 · Cited by 6
In silico evidence of de novo interactions between ribosomal and Epstein - Barr virus proteins
Sim, E. U., & Talwar, S. P. (2019) · BMC Molecular and Cell Biology · doi:10.1186/s12860-019-0219-y · Cited by 6
“…crystal structure of eukaryotic 40S ribosomal subunit in complex with initiation factor-1 (PDB ID: 2XZM) at CSNK2A1 anti-tag co-immunoprecipitation [15] CSNK2B tandem affinity purification [14] LMP1 RABAC1 two-hybrid [16] UBE2I anti-bait co-immunoprecipitation [17] TRADD anti-bait…”
MethodFrappier, L. (2025) · Current topics in microbiology and immunology · doi:10.1007/82_2025_299 · Cited by 5
Self-citationRational Computational Workflow for Structure-Guided Discovery of a Novel USP7 Inhibitor
Srivastava, M., Kumari, D., Majumder, S., Singh, N., Mathur, R., Maiti, T. K., Kumar, A., & Asthana, S. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01400 · Cited by 6
Histone variant H2A.Z cooperates with EBNA1 to maintain Epstein-Barr virus latent epigenome
Castro-Muñoz, L. J., Maestri, D., Yoon, L., Karisetty, B. C., Tempera, I., & Lieberman, P. M. (2025) · mBio · doi:10.1128/mbio.00302-25 · Cited by 7
“Z loading, such as nucleosome assembly protein 1 (NAP1) (52, 53).”
Sun, Y., Liu, W., & Luo, B. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04561-2 · Cited by 5
Epstein–Barr Virus: Overcoming the DNA Damage Response
Frappier, L. (2019) · Future Virology · doi:10.2217/fvl-2019-0015 · Cited by 5
Self-citationUbiquitin Family Members in the Regulation of the Tumor Suppressor p53
Xirodimas, D. P., & Scheffner, M. (2010) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4419-6676-6_10 · Cited by 5
Role of deubiquitylase HAUSP in stem cell maintenance
Huang, Z., Zhou, W., & Bao, S. (2011) · Cell Cycle · doi:10.4161/cc.10.8.15260 · Cited by 6
Affinity Purification–Mass Spectroscopy Methods for Identifying Epstein–Barr Virus–Host Interactions
Georges, A. A., & Frappier, L. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6655-4_5 · Cited by 4
Self-citationProteomic approaches to investigate gammaherpesvirus biology and associated tumorigenesis
Chappell, D. L., White, M. C., & Damania, B. (2020) · Advances in virus research · doi:10.1016/bs.aivir.2020.10.001 · Cited by 6
“To understand some critical interacting regulators of EBNA-1, Holowaty and colleagues utilized TAP-tagged EBNA-1.”
BackgroundInfluentialHuman Viral Oncoproteins and Ubiquitin–Proteasome System
Atani, Z. R., Hosseini, S. S., Goudarzi, H., & Faghihloo, E. (2024) · Global Medical Genetics · doi:10.1055/s-0044-1790210 · Cited by 4
Shahab, M., Waqas, M. S., Fahira, A., Zhang, H., & Huang, Z. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.111246 · Cited by 4
Aggressive Mature Natural Killer Cell Neoplasms: From EBV-Infection to Disease Etiopathogeny
Lima, M. (2014) · Journal of Blood Disorders & Transfusion · doi:10.4172/2155-9864.1000193 · Cited by 3
Johannsen, E., Calderwood, M. A., Kang, M.-S., Zhao, B., Portal, D., & Kieff, E. D. (2008) · Springer eBooks · doi:10.1007/978-0-387-68945-6_14 · Cited by 3
Huang, Z., Zhai, K., Wu, Q., Fang, X., Huang, Q., Tao, W., Lathia, J. D., Yu, J. S., Rich, J. N., & Bao, S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.09.447550 · Cited by 3
Ubiquitin-Specific Protease USP7
Faesen, A. C., Sixma, T. K., & Everett, R. D. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382219-2.00463-4 · Cited by 2
Epstein-barr virus nuclear antigen 1, oct & groucho/TLE in control of promoter regulation
Almqvist, J. (2005) · Figshare · Cited by 2
Modulation of the innate immune response by the oncoviruses EBV and HPV
Parroche, P. (2011) · theses.fr (ABES) · doi:10.70675/1123b896zdfdaz408az9372z41cc116e27df · Cited by 3
Application of functional proteomics in understanding RNA virus-mediated infection
Panda, M., Kalita, E., Singh, S., Rao, A., & Prajapati, V. K. (2023) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2023.04.004 · Cited by 1
Yang, X., Jiang, F. Z., Li, J., Wu, Y., & Xiang, H. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10266-7 · Cited by 1
“In contrast, (Epstein–Barr nuclear antigen 1) (Daubeuf 2009; Holowaty 2003 ).”
EBNA1 SUMOylation by PIAS1 suppresses EBV lytic replication and enhances episome maintenance
Sugiokto, F. G., Zhang, K., Maharjan, Y., & Li, R. (2025) · mBio · doi:10.1128/mbio.02639-25 · Cited by 1
“GAr region is particularly important for segregation and transcriptional activation functions (32, 37).”
EBNA1 inhibitors reveal CDC7 and POU2F1 as direct functional targets in EBV epithelial cancers
He, S., Terhuja, N., Soldan, S. S., Chen, C., Cassel, J., Yin, X., Liu, Q., Chung, S. S., Castro-Muñoz, L. J., Yoon, L., et al. (2026) · mBio · doi:10.1128/mbio.00329-26 · Cited by 1
“…studies have identified key functions of the EBNA1 N-terminal region in chromosome tethering (66), transcriptional activation (67), nuclear localization (68), as well as interactions with histone H1 (69, 70), BRD4 (71), USP7 (72), CK2 (73, 74), and RNAs (75, 76), including G-quadruplexes (77, 78).”
Epstein-Barr Virus and Its Oncogenesis
Li, H., Chao, M., Chen, S., & Chang, Y. (2009) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789812833471_0005 · Cited by 1
Interactions between Viruses and the Ubiquitin–Proteasome System
Boname, J. M., & Lehner, P. J. (2007) · Wiley eBooks · doi:10.1002/9783527620234.ch7 · Cited by 1
Predicted cellular interactors of the endogenous retrovirus-K protease enzyme
Narvey, S., Vandenakker, A., Rempel, M., & Douville, R. N. (2022) · Frontiers in Virology · doi:10.3389/fviro.2022.972156 · Cited by 1
“Similarly, the Epstein-Barr nuclear antigen 1 (EBNA1) protein of EBV also preferentially binds the TRAF domain of USP7, resulting in destabilizing p53 and reducing p53 levels (91, 92).”
BackgroundOverview of the Large DNA Tumor Viruses
Verma, S. C., Cai, Q., Bajaj, B. G., & Robertson, E. S. (2008) · Springer eBooks · doi:10.1007/978-0-387-68945-6_8 · Cited by 1
Roles of EBNA1 at EBV Episomes
Frappier, L. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6886-8_2 · Cited by 1
Self-citationInteractions between Viruses and the Ubiquitin–Proteasome System
Boname, J. M., & Lehner, P. J. (2007) · Wiley eBooks · doi:10.1002/9783527619320.ch7c · Cited by 1
Targeting HAUSP: Killing Two Birds with One Stone
Brooks, C. L., & Gu, W. J. (2009) · Springer eBooks · doi:10.1007/978-0-387-69147-3_3
“HSV-1 gene products, ICP0, and the Epstein-Barr virus (EBV) nuclear antigen protein EBNA-1 (Everett et al. 1997 ; Holowaty et al. 2003 ) . In the case of ICP0, a viral E3 ubiquitin ligase, there appears to be a reciprocal relationship between the two proteins.”
BackgroundFrappier, L. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6886-8_5
Self-citation
Metadata
- Authors
- Holowaty, M. N., Zeghouf, M., Wu, H., Tellam, J., Athanasopoulos, V., Greenblatt, J., & Frappier, L.
- Affiliations
- University of Toronto (CA)
- QIMR Berghofer Medical Research Institute (AU)
- Corresponding author
- Frappier, Lori
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-08
- Volume
- 278
- Issue
- 32
- Pages
- 29987-29994
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2031857756
- Cited by
- 228
- References
- 55
- Citations by year
- 2026: 3 · 2025: 11 · 2024: 4 · 2023: 5 · 2022: 13 · 2021: 9 · 2020: 8 · 2019: 14 · 2018: 8 · 2017: 4 · 2016: 4 · 2015: 6 · 2014: 10 · 2013: 15 · 2012: 13
- FWCI
- 3.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6269 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Keywords
- EBNA1, Epstein-Barr virus, ubiquitin-specific protease, protein-protein interaction, NAP1, sets, casein kinase 2, PRMT5, latent viral genome
- MeSH terms
- Ubiquitin-Specific Peptidase 7, Animals, Cell Line, Chromatography, Affinity, Electrophoresis, Polyacrylamide Gel, HeLa Cells, Humans, Insecta, Microscopy, Fluorescence, Models, Genetic, Mutation, Endopeptidases, Plasmids, Precipitin Tests, Protein-Arginine N-Methyltransferases, Protein Binding, Protein Methyltransferases, Sodium Chloride, Mass Spectrometry, Transcriptional Activation, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Epstein-Barr Virus Nuclear Antigens, Ubiquitin Thiolesterase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.